Natural Product: NPC502109

Natural Product IDNPC502109
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
(2~{R},3~{S})-2-(3,4-dihydroxyphenyl)-6-[4,5-dihydroxy-2-[(2~{R},3~{S})-3,5,7-trihydroxychroman-2-yl]phenyl]chromane-3,5,7-triol
IUPAC Name (2~{R},3~{S})-2-(3,4-dihydroxyphenyl)-6-[4,5-dihydroxy-2-[(2~{R},3~{S})-3,5,7-trihydroxychroman-2-yl]phenyl]chromane-3,5,7-triol
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier n.a.
PubChem CID n.a.
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey RIGUICSQBGRGSL-BAAZAXTHSA-N
Standard InCHI InChI=1S/C30H26O12/c31-12-4-18(33)15-8-24(39)30(42-25(15)5-12)14-7-21(36)20(35)6-13(14)27-22(37)10-26-16(28(27)40)9-23(38)29(41-26)11-1-2-17(32)19(34)3-11/h1-7,10,23-24,29-40H,8-9H2/t23-,24-,29+,30+/m0/s1
SMILES OC1=CC(O)=C2C[C@H](O)[C@@H](C3=CC(O)=C(O)C=C3C3=C(O)C=C4O[C@H](C5=CC=C(O)C(O)=C5)[C@@H](O)CC4=C3O)OC2=C1

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   578.14 Volume:   549.942
?
Van der Waals volume.
Dense:   1.051 LogP:   1.1
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   1.231
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -3.534
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   3.0 Rigid Bonds:   34.0
TPSA:   220.76
?
Topological Polar Surface Area.
H-Bond Acceptor:   12.0
H-Bond Donor:   10.0 Rings:   6.0
Heavy Atoms:   12.0

MedChem Properties

QED Drug-Likeness Score:   0.159 GASA:   1.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   4.502 Fsp3:   0.2
MCE-18:   126.667
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Accepted
Pfizer Rule:   Rejected GSK Rule:   Accepted
Golden Triangle Rule:   Accepted BMS Rule:   1
Chelating Alert:   1 PAINS Alert:   1
Colloidal aggregators:   0.764 Fluc inhibitor:   0.297
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.924
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.51
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.564 Promiscuous compounds:   0.261

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -7.101 MDCK Permeability:   -4.858
Pgp-inhibitor:   0.0 Pgp-substrate:   0.171
PAMPA:   0.944
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.001
20% Bioavailability (F20%):   0.956 30% Bioavailability (F30%):   1.0
50% Bioavailability (F50%):   1.0

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.0 MRP1:   0.972
Plasma Protein Binding (PPB):   92.246% Volume Distribution (VD):   0.117
Fu: 11.81%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.994
OATP1B3 inhibitor:   0.991 BCRP inhibitor:   0.001
BSEP inhibitor:   0.002

ADMET: Metabolism

CYP1A2-inhibitor:   0.007 CYP1A2-substrate:   0.0
CYP2C19-inhibitor:   0.0 CYP2C19-substrate:   0.0
CYP2C9-inhibitor:   0.0 CYP2C9-substrate:   0.0
CYP2D6-inhibitor:   0.0 CYP2D6-substrate:   0.163
CYP3A4-inhibitor:   0.006 CYP3A4-substrate:   0.776
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   0.097
HLM stability:   0.0
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  9.386 Half-life (T1/2):  3.9

ADMET: Toxicity

hERG Blockers:  0.137 hERG Blockers (10um):  0.766
Human Hepatotoxicity (H-HT):  0.774 Drug-induced Liver Injury (DILI):  0.319
AMES Toxicity:  0.509 Rat Oral Acute Toxicity:  0.374
Maximum Recommended Daily Dose:  0.976 Skin Sensitization:  0.998
Carcinogencity:  0.067 Eye Corrosion:  0.0
Eye Irritation:  0.741 Respiratory Toxicity:  0.6
Drug-induced Neurotoxicity:  0.006 Ototoxicity:  0.96
Hematotoxicity:  0.011 Drug-induced Nephrotoxicity:  0.129
Genotoxicity:  0.988 RPMI-8226 Immunitoxicity:  0.04
A549 Cytotoxicity:  0.998 Hek293 Cytotoxicity:  0.903
BCF:   1.002
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   3.503
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   4.644
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   4.053
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO11804 Potentilla erecta Species Rosaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO11804 Potentilla erecta Species Rosaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC502109 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.7119 Intermediate Similarity NPC261619
0.7119 Intermediate Similarity NPC61477
0.7119 Intermediate Similarity NPC78770
0.7119 Intermediate Similarity NPC219876
0.7119 Intermediate Similarity NPC126029
0.7119 Intermediate Similarity NPC15658
0.5968 Remote Similarity NPC207179
0.5968 Remote Similarity NPC167571
0.5968 Remote Similarity NPC278552
0.5811 Remote Similarity NPC28440
0.5714 Remote Similarity NPC268266
0.5714 Remote Similarity NPC42760
0.5714 Remote Similarity NPC220825
0.5714 Remote Similarity NPC268342
0.5588 Remote Similarity NPC171932
0.5405 Remote Similarity NPC58190
0.5405 Remote Similarity NPC108811
0.5405 Remote Similarity NPC170103
0.5405 Remote Similarity NPC236202
0.5405 Remote Similarity NPC262911
0.5405 Remote Similarity NPC202742
0.5362 Remote Similarity NPC16435
0.5333 Remote Similarity NPC246202
0.5333 Remote Similarity NPC224161
0.5333 Remote Similarity NPC46335
0.5333 Remote Similarity NPC294558
0.5333 Remote Similarity NPC18185
0.5333 Remote Similarity NPC263940
0.5333 Remote Similarity NPC279406
0.5333 Remote Similarity NPC486519
0.5077 Remote Similarity NPC601844
0.5075 Remote Similarity NPC47398
0.5075 Remote Similarity NPC234333
0.5075 Remote Similarity NPC260898
0.5072 Remote Similarity NPC61946

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC502109 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.7119 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7119 Intermediate Similarity NPD1613 Phase 4

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data